OFFICIAL PUBLICATION OF

by its subsidiary APPco

Research Roundup

Debbie Rigby 02/02/2021

Debbie Rigby rounds up the latest in research news Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes A large systematic review and network meta-analysis of 764 randomised controlled trials has concluded that SGLT-2 inhibitors and GLP-1 receptor agonists reduced cardiovascular and renal outcomes in patients with type 2

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Doctor title ‘recognition and respect you deserve’

If that's true then release all internal emails between the Guild and universities/government bodies. You're purely just advocating and hoping…

John Smith

Doctor title ‘recognition and respect you deserve’

A huge amount of John's comments are outright xenophobic. There is no point trying to reason with someone who thinks…

Siya Etzebeth

Doctor title ‘recognition and respect you deserve’

Still not answering the question. Just building up more strawmen. If you're confident that you are correct then stop lying…

Siya Etzebeth

Doctor title ‘recognition and respect you deserve’

The Guild doesn't "direct" anyone openly but they hold a lot of power and it's either nieve or disingenous to…

John Smith

Research Roundup

Previous The debate goes on

Next Time running out on APP2021 Super Early Bird savings

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous The debate goes on

Next Time running out on APP2021 Super Early Bird savings

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.